Jul 31, 2023 4:01 pm EDT Atara Biotherapeutics to Participate in the Canaccord Genuity 43rd Annual Growth Conference
Jul 07, 2023 4:01 pm EDT Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 07, 2023 4:01 pm EDT Atara Biotherapeutics to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
Jun 05, 2023 9:00 am EDT Atara Biotherapeutics Presents Updated Tab-cel® Clinical Effectiveness Data at ASCO 2023
Jun 02, 2023 4:01 pm EDT Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 08, 2023 4:01 pm EDT Atara Biotherapeutics Announces First Quarter 2023 Financial Results and Operational Progress
May 05, 2023 4:01 pm EDT Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 01, 2023 4:01 pm EDT Atara Biotherapeutics to Announce First Quarter 2023 Financial Results on Monday, May 8, 2023
Mar 31, 2023 4:01 pm EDT Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 03, 2023 4:01 pm EST Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)